Adenocarcinoma, Papillary
Recent clinical, regulatory, research and industry developments relating to this disease.
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- Cancer discovery1
Leading researchers8
- Andreatta M1
- Barras D1
- Benedetti F1
- Berthold DR1
- Bourhis J1
- Carmona SJ1
- Corria-Osorio J1
- Coukos G1
Affiliations (unnormalised)6
- Attikon University Hospital1
- Center for Systems Biology1
- Center of Experimental Therapeutics1
- Institute of Pathology1
- Lausanne University Hospital1
- Ludwig Institute for Cancer Research1
Reference
Authoritative identity, definition & identifiers.
An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.